Company Profiles

driven by the PitchBook Platform

Proteo Design

Proteo Design
2012 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
1 INVESTORS
Description

Developer of protein modification technologies for cancer treatment. The company is developing therapeutic protein conjugate to kill cancer cells.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
Parc Científic de Barcelona
Baldiri Reixac, 10-12
08028 Barcelona
Spain

+34 934 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Proteo Design’s full profile, request a free trial.

Proteo Design Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 13-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Proteo Design Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Caixa Capital Risc Corporate Venture Capital Minority 000 0000 000000 0

Proteo Design Executive Team (3)

Name Title Board
Seat
Contact
Info
Silvia Frutos Ph.D Co-Founder & Chief Operating Officer
Miquel Vila-Perelló Ph.D Co-Founder, Managing Director and Chief Science Officer
Thomas Muir Ph.D Co-Founder & Scientific Advisor

Proteo Design Board Members (4)

Name Representing Role Since Contact
Info
Alex Casta Ruiz Ph.D Proteo Design Board Member 000 0000
Jose Antonio Mesa Cejudo Proteo Design Board Member 000 0000
Marc Litchfield Proteo Design Co-Founder & Board Member 000 0000
William Middlekauff Proteo Design Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com